Measurement Properties of the Persian Translated Version of Graves Orbitopathy Quality of Life Questionnaire: A Validation Study

References

• Kashkouli MB. Beyond a typical thyroid eye disease. Middle East Afr J Ophthalmol 2013;20:185–186.
   PubMedGoogle Scholar
• Kashkouli MB, Jam S, Sabzvari D, et al. Thyroid-associated ophthalmopathy in Iranian patients. Acta Med Iran 2011;49:612–618.
   PubMedGoogle Scholar
• Kashkouli MB, Kaghazkanani R, Heidari I, et al. Bilateral versus unilateral thyroid eye disease. Indian J Ophthalmol 2011;59:363–366.
   PubMed Web of Science ®Google Scholar
• Park JJ, Sullivan TJ, Mortimer RH, et al. Assessing quality of life in Australian patients with Graves’ ophthalmopathy. Br J Ophthalmol 2004;88:75–78.
   PubMed Web of Science ®Google Scholar
• Choi YJ, Lim HT, Lee SJ, et al. Assessing Graves’ ophthalmopathy-specific quality of life in Korean patients. Eye 2012;26:544–551.
   PubMed Web of Science ®Google Scholar
• Kashkouli M, Pakdel F, Astaraki A, et al. Quality of life in patients with thyroid eye disease. J Ophthalmic Vis Res 2009;4:164–168.
   PubMedGoogle Scholar
• Gerding MN, Terwee CB, Dekker FW, et al. Quality of life in patients with Graves ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 1997;7:885–889.
   PubMed Web of Science ®Google Scholar
• Prummel MF, Mourits MP, Blank L, et al. Randomized double-blind trial of prednisone versus radiotherapy in Graves’ ophthalmopathy. Lancet 1993;342:949–954.
   PubMed Web of Science ®Google Scholar
• Terwee CB, Gerding MN, Dekker FW, et al. Test-retest reliability of the GO-QOL: a disease-specific quality of life questionnaire for patients with Graves’ ophthalmopathy. J Clin Epidemiol 1999;52:875–884.
   PubMed Web of Science ®Google Scholar
• Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007;60:34–42.
   PubMed Web of Science ®Google Scholar
• http://www.eugogo.eu/clinical_evaluation.php#, Accessed 1 December 2015.
   Google Scholar
• Werner SC. Modification of the classification of the eye changes of Graves’ disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 1977;44:203–204.
   PubMed Web of Science ®Google Scholar
• Mourits MP, Prummel MF, Wiersinga WM, et al. Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin Endocrinol (Oxf) 1997;47:9–14.
   PubMed Web of Science ®Google Scholar
• Kashkouli MB, Nojomi M, Parvaresh MM, et al. Normal values of hertel exophthalmometry in children, teenagers, and adults from Tehran, Iran. Optom Vis Sci 2008;85:1012–1017.
   PubMed Web of Science ®Google Scholar
• van Kampen DA, van Beers LW, Scholtes VA, et al. Validation of the Dutch version of the Simple Shoulder Test. J Shoulder Elbow Surg 2012;21:808–814.
   PubMed Web of Science ®Google Scholar
• Nunnally JC, Bernstein IH. Psychometric theory, 3rd ed. New York: McGraw-Hill, 1994.
   Google Scholar
• Bond TG, Fox CM. Applying the Rasch model: fundamental measurement in the human sciences, 2nd ed. Mahwah, NJ: Lawrence Erlbaum Associates Publishers, 2007.
   Google Scholar
• Embretson SE, Reise SP. Item response theory for psychologists. Mahwah, NJ: Lawrence Erlbaum Associates, 2000.
   Google Scholar
• Wilson M. Constructing measures: an item response modeling approach. Mahwah, NJ: Lawrence Erlbaum Associates, 2005.
   Google Scholar
• de Vet HC, Ader HJ, Terwee CB, et al. Are factor analytical techniques used appropriately in the validation of health status questionnaires? A systematic review on the quality of factor analysis of the SF-36. Qual Life Res 2005;14:1203–1218; discussion 1219–1221,1223–1224.
   PubMed Web of Science ®Google Scholar
• Scholtes VA, Terwee CB, Poolman RW. What makes a measurement instrument valid and reliable? Injury 2011;42:236–240.
   PubMed Web of Science ®Google Scholar
• Terwee CB, Gerding MN, Dekker FW, et al. Development of a disease specific quality of life questionnaire for patients with Graves’ ophthalmopathy: the GO-QOL. Br J Ophthalmol 1998;82:773–779.
   PubMed Web of Science ®Google Scholar
• Terwee CB, Dekker FW, Mourits MP, et al. Interpretation and validity of changes in scores on the Graves’ ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. Clin Endocrinol (Oxf) 2001;54:391–398.
   PubMed Web of Science ®Google Scholar
• Wiersinga WM, Prummel MF, Terwee CB. Effects of Graves’ ophthalmopathy on quality of life. J Endocrinol Invest 2004;27:259–264.
   PubMed Web of Science ®Google Scholar
• Kashkouli MB, Heidari I, Pakdel F, et al. Change in quality of life after medical and surgical treatment of Graves’ ophthalmopathy. Middle East Afr J Ophthalmol 2011;18:42–47.
   PubMedGoogle Scholar
• Estcourt S, Quinn AG, Vaidya B. Quality of life in thyroid eye disease: impact of quality of care. Eur J Endocrinol 2011;164:649–655.
   PubMed Web of Science ®Google Scholar
• Ponto KA, Hommel G, Pitz S, et al. Quality of life in a German Graves orbitopathy population. Am J Ophthalmol 2011;152:483–490e481.
   PubMed Web of Science ®Google Scholar
• Nasr E, Khater S, Nehme-Nasr D, et al. Corticosteroids and radiotherapy in the treatment of Graves’ ophthalmopathy. J Med Liban 2010;58:86–90.
   PubMedGoogle Scholar
• Aktaran S, Akarsu E, Erbagci I, et al. Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves’ ophthalmopathy. Int J Clin Pract 2007;61:45–51.
   PubMed Web of Science ®Google Scholar
• Mokkink LB, Terwee CB, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 2010;19:539–549.
   PubMed Web of Science ®Google Scholar
• Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993;46:1417–1432.
   PubMed Web of Science ®Google Scholar
• Marcocci C, Kahaly GJ, Krassas GE, et al. Selenium and the course of mild Graves’ orbitopathy. N Engl J Med 2011;364:1920–1931.
   PubMed Web of Science ®Google Scholar
• Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010;63:737–745.
   PubMed Web of Science ®Google Scholar
• Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr Res Anesth Analg 1953;32:260–267.
   PubMedGoogle Scholar
• Streiner DL. Being inconsistent about consistency: when coefficient alpha does and doesn’t matter. J Pers Assess 2003;80:217–222.
   PubMed Web of Science ®Google Scholar
• Wiersinga WM. Quality of life in Graves’ ophthalmopathy. Best Pract Res Clin Endocrinol Metab 2012;26:359–370.
   PubMed Web of Science ®Google Scholar
• Sijtsma K. On the use, the misuse, and the very limited usefulness of Cronbach’s alpha. Psychometrika 2009;74:107–120.
   PubMed Web of Science ®Google Scholar